These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26587994)

  • 1. Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.
    Maity AR; Stepensky D
    Mol Pharm; 2016 Jan; 13(1):1-7. PubMed ID: 26587994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of drugs to intracellular organelles using drug delivery systems: Analysis of research trends and targeting efficiencies.
    Maity AR; Stepensky D
    Int J Pharm; 2015 Dec; 496(2):268-74. PubMed ID: 26516100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'IntraCell' plugin for assessment of intracellular localization of nano-delivery systems and their targeting to the individual organelles.
    Sneh-Edri H; Stepensky D
    Biochem Biophys Res Commun; 2011 Feb; 405(2):228-33. PubMed ID: 21219848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Subcellular Targeting to the Cell Nucleus of Quantum Dots Densely Decorated with a Nuclear Localization Sequence Peptide.
    Maity AR; Stepensky D
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):2001-9. PubMed ID: 26731220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient decoration of nanoparticles intended for intracellular drug targeting with targeting residues, as revealed by a new indirect analytical approach.
    Kaplun V; Stepensky D
    Mol Pharm; 2014 Aug; 11(8):2906-14. PubMed ID: 25040658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems.
    Kozlovskaya L; Stepensky D
    J Control Release; 2013 Oct; 171(1):17-23. PubMed ID: 23831053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear and perinuclear targeting efficiency of quantum dots depends on density of peptidic targeting residues on their surface.
    Maity AR; Stepensky D
    J Control Release; 2017 Jul; 257():32-39. PubMed ID: 28042083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular delivery of nanocarriers and targeting to subcellular organelles.
    Jhaveri A; Torchilin V
    Expert Opin Drug Deliv; 2016; 13(1):49-70. PubMed ID: 26358656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future of nanotherapeutics: Targeting the cellular sub-organelles.
    Ma X; Gong N; Zhong L; Sun J; Liang XJ
    Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
    Torchilin VP
    Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of drug delivery to the brain via nasal route.
    Kozlovskaya L; Abou-Kaoud M; Stepensky D
    J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?
    Field LD; Delehanty JB; Chen Y; Medintz IL
    Acc Chem Res; 2015 May; 48(5):1380-90. PubMed ID: 25853734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.
    D'Souza GG; Weissig V
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1135-48. PubMed ID: 19708822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the study of organelles targeting nanocarriers].
    Sun XY; Wei LL; Chen HL; Liang WQ
    Yao Xue Xue Bao; 2009 Aug; 44(8):838-44. PubMed ID: 20055149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-anchored drugs for delivery into subcellular compartments.
    Rajendran L; Udayar V; Goodger ZV
    Trends Pharmacol Sci; 2012 Apr; 33(4):215-22. PubMed ID: 22385603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular visualization: Organelle-specific targeted drug delivery and discovery.
    Shao X; Meng C; Song W; Zhang T; Chen Q
    Adv Drug Deliv Rev; 2023 Aug; 199():114977. PubMed ID: 37391014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.
    Hayashi Y; Hatakeyama H; Kajimoto K; Hyodo M; Akita H; Harashima H
    Bioconjug Chem; 2015 Jul; 26(7):1266-76. PubMed ID: 25938819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
    Singh D
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1480-1487. PubMed ID: 38303531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organelle-Targeting Gold Nanorods for Macromolecular Profiling of Subcellular Organelles and Enhanced Cancer Cell Killing.
    Shen Y; Liang L; Zhang S; Huang D; Deng R; Zhang J; Qu H; Xu S; Liang C; Xu W
    ACS Appl Mater Interfaces; 2018 Mar; 10(9):7910-7918. PubMed ID: 29436215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.